3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
16
Carcinoma, Non-Small-Cell Lung
8
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Urothelial Cancer
1
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Malignancies
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Hypertension, Portal
1
Hepato Cellular Carcinoma
1
Hematologic Neoplasms
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma
1
Interventions
Oxaliplatin
24
Fluorouracil
20
Capecitabine
16
pembrolizumab
15
Nivolumab
15
Leucovorin
13
Trastuzumab
9
fludarabine
8
Paclitaxel
8
Drug Therapy
8
Docetaxel
8
Cyclophosphamide
8
S 1 (combination)
7
trastuzumab deruxtecan
6
Specimen Handling
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Bevacizumab
5
zolbetuximab
4
Irinotecan
4
Biopsy
4
zimberelimab
3
sintilimab
3
fludarabine phosphate
3
atezolizumab
3
aldesleukin
3
XELOX
3
Surgical Procedures, Operative
3
Ramucirumab
3
Radiotherapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
tremelimumab
×
90 days
×
Clear all
No trials found.